REVERSED
Tech Center 1600 Biotechnology and Organic Chemistry
1644 Ex Parte Berggren 10834525 - (D) PAULRAJ 112(1) MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP EWOLDT, GERALD R
It has been held that the in vitro screening for compounds that exhibit a pharmacological activity “may establish a practical utility for the compound in question” because “[s]uccessful in vitro testing will marshal resources and direct the expenditure of effort to further in vivo testing of the most potent compounds, thereby providing an immediate benefit to the public, analogous to the benefit provided by the showing of an in vivo utility.” Cross v. Iizuka, 753 F.2d 1040, 1051 (Fed. Cir. 1985); see also Nelson v. Bowler, 626 F.2d 853, 856 (CCPA 1980) (“[T]ests evidencing pharmacological activity may manifest a practical utility even though they may not establish a specific therapeutic use.”).
Cross v. Iizuka, 753 F.2d 1040, 224 USPQ 739 (Fed. Cir. 1985) 2107.01 , 2107.03 , 2164.02
Nelson v. Bowler, 626 F.2d 853, 206 USPQ 881 (CCPA 1980) 2107.01 , 2107.02 , 2107.03 , 2138.05
Tech Center 2100 Computer Architecture and Software
2192 Ex Parte Degenhardt et al 11580946 - (D) SHIANG 102/103 CAMPBELL STEPHENSON LLP CHOWDHURY, ZIAUL A.
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2814 Ex Parte Saxler et al 12253387 - (D) HOUSEL 103 MYERS BIGEL SIBLEY & SAJOVEC, P.A. RAO, SHRINIVAS H
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3617 Ex Parte Iden 12490966 - (D) CALVE 103 Pillsbury Winthrop Shaw Pittman, LLP (NV) SMITH, JASON C
3679 Ex Parte Kelley 12386897 - (D) KRATZ 103 Thomas E. Kelley FERGUSON, MICHAEL P
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3736 Ex Parte AOKI et al 12418780 - (D) PER CURIAM 102 SCULLY SCOTT MURPHY & PRESSER, PC HOEKSTRA, JEFFREY GERBEN
3777 Ex Parte Wohlgemuth 11747489 - (D) SCHOPFER 103 Tucker Ellis LLP Brainlab AG BRUTUS, JOEL F
AFFIRMED-IN-PART
Tech Center 1700 Chemical & Materials Engineering
1783 Ex Parte Kudva et al 12732597 - (D) COLAIANNI 103 102 CORNING INCORPORATED AUER, LAURA A
Titanium Metals Corp. v. Banner, 778 F.2d 775 (Fed. Cir. 1985) (“[W]hen by recitation of ranges or otherwise, a claim covers several compositions, the claim is ‘anticipated’ if one of them is in the prior art.”).
Titanium Metals Corp. of America v. Banner, 778 F.2d 775, 227 USPQ 773 (Fed. Cir. 1985) 2112.01 , 2131.01 , 2131.03 , 2144.05
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2464 Ex Parte Wilson 12509974 - (D) BUI 102 102/103 Conley Rose - BlackBerry Files NG, CHRISTINE Y
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2894 Ex Parte Andrews 12145280 - (D) HOUSEL 103 103 37 C.F.R. § 41.50(b) 103 MYERS BIGEL SIBLEY & SAJOVEC, P.A. LAURENZI, MARK A
AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1646 Ex Parte Sanders et al 12165847 - (D) GRIMES 103 37 C.F.R. § 41.50(b) 103 LOWENSTEIN SANDLER LLP FORD, VANESSA L
Tech Center 1700 Chemical & Materials Engineering
1761 Ex Parte Taylor 13067574 - (D) NAGUMO 102 ANDREA HENCE EVANS, LLC BOYER, CHARLES I
Tech Center 2600 Communications
2683 Ex Parte Kim 11704148 - (D) BAER 103 THE FARRELL LAW FIRM, P.C. NGUYEN, AN T
REHEARING
GRANTED–IN–PART
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3773 Ex Parte Santilli et al 11610836 - (D) POLLOCK 102 102/103 LAW OFFICES OF WAYNE D. PORTER, JR. HOUSTON, ELIZABETH
REEXAMINATION
AFFIRMED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3763 GLYSURE LTD. Respondent, Requester v. Patent of GLUMETRICS, INC. Appellant, Patent Owner Ex Parte 8,088,097 B2 et al 12/274,617 95002142 - (D) McCARTHY 112(2) KNOBBE MARTENS OLSON & BEAR LLP MEDTRONIC MINIMED, INC. Third Party Requester: FISH & RICHARDSON P.C. (TC) FLANAGAN, BEVERLY MEINDL original MENDEZ, MANUEL A
